Anorexia Nervosa, Atypical
10
2
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
10.0%
1 terminated out of 10 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (10)
3-Dimensional Optical Scanning to Assess and Monitor Malnutrition in Eating Disorders (3D-ED) Study
App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa
Naltrexone Neuroimaging in Teens With Eating Disorders
Frequency of Hypermobility-Related Problems in Patients With Anorexia Nervosa
Oral Naltrexone In Pediatric Eating Disorders
Online Relapse Prevention Study
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
Emotional Dysregulation, Maladaptive Overcontrol in Anorexia - Effect of Radically Open Dialectical Behaviour Therapy
Adaptive Treatment for Adolescent Anorexia Nervosa
Implementation of Evidence-Based Treatment of Restrictive Eating Disorder With Pronounced Starvation